Do “Right to Try” laws grant patients access to experimental drugs?

Simple item page
dc.contributor.authorMatthews, Kirstin R.W.en_US
dc.contributor.authorRubin, Michelle J.en_US
dc.contributor.orgJames A. Baker III Institute for Public Policyen_US
dc.date.accessioned2016-11-10T21:23:52Zen_US
dc.date.available2016-11-10T21:23:52Zen_US
dc.date.issued2016en_US
dc.descriptionDo “Right to Try” laws grant patients access to experimental drugs? In this Health Policy Research newsletter, Science and technology policy fellow Kirstin R.W. Matthews and intern Michelle Rubin examine the impact of state laws that grant terminally ill patients access to early investigational drugs before clinical trials are completed.en_US
dc.identifier.citationMatthews, Kirstin R.W. and Rubin, Michelle J.. "Do “Right to Try” laws grant patients access to experimental drugs?." <i>The Baker Institute Policy Report,</i> 11, no. 3 (2016) James A. Baker III Institute for Public Policy;Rice University;Baylor College of Medicine: <a href="http://www.bakerinstitute.org/research/health-policy-newsletter-september-2016/">http://www.bakerinstitute.org/research/health-policy-newsletter-september-2016/</a>.en_US
dc.identifier.urihttps://hdl.handle.net/1911/92695en_US
dc.titleDo “Right to Try” laws grant patients access to experimental drugs?en_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
HPR-Newsletter-Sept2016.pdf
Size:
1.03 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Baker Institute Publications